The PPMI News page provides updates on the latest PPMI developments, including information on the progress of PD biomarker research, scientific publications and presentations, clinical site and recruitment news, as well as articles in the media that feature the study. Sign up for email updates to be notified when new posts are added.

PPMI News Get updates: Email RSS

Recent Posts

PPMI Steering Committee Paper Accepted to Movement Disorders Journal

Apr 5, 2018

We are excited to announce a recent research article using longitudinal data from PPMI has been accepted to Movement Disorders.  Members of the PPMI Steering Committee, including Dr. Tanya Simuni of Northwestern University, authored this publication on behalf of PPMI. The study, entitled “Longitudinal Change of Clinical and Biological Measures in Early Parkinson’s Disease: Parkinson’s […]

Continue reading...

PPMI Study Update Call – 3/15/18

Feb 21, 2018

PPMI Study Update Call Thursday, March 15 12-1 pm Eastern Time Andrew Siderowf, MD, MSCE Professor of Neurology University of Pennsylvania Co-Principal Investigator of PPMI   PPMI participants are encouraged to call in to the next quarterly Study Update Call on Thursday, March 15, 2018 at 12 pm EST.  During this call, Dr. Andrew Siderowf, […]

Continue reading...

iPSC Sub-study Complete

Feb 20, 2018

PPMI is a nimble study designed to allow for quick adaptation to emerging needs in the Parkinson’s disease (PD) research field.  In response to increased interest from researchers in well-characterized induced pluripotent stem cells (iPSCs) – adult cells capable of giving rise to any human cell type – PPMI launched the Golub Capital iPSC Sub-Study […]

Continue reading...

Participant Update Call – 6/28/2017

Jun 27, 2017

All PPMI participants are encouraged to call in for our quarterly study update call, tomorrow at 12 pm EST. Dr. Daniel Weintraub will discuss the impact of PD on cognition. Dr. Weintraub’s talk will center around his recent publication of PPMI data in the journal PLoS One. You can read the full research article online.

Continue reading...

Update: PPMI iPSC Lines

Jun 19, 2017

Cell lines derived from PPMI participants’ PBMCs become available on a rolling basis as they are reprogrammed; some lines are available now. For more information, please email resources@michaeljfox.org. Information about additional tools for PD research – including animal models, antibodies, and assays, can be found on the Michael J. Fox Foundation website.   The Parkinson’s […]

Continue reading...

PPMI at MDS 2017

May 30, 2017

The 21st International Congress of Parkinson’s Disease and Movement Disorders (MDS) conference will take place next week, June 4-8, in Vancouver, Canada. PPMI leadership is happy to announce that several posters will feature PPMI data. We invite you to look for PPMI at this year’s meeting:   Blue Ribbon Highlight:  840 “Multiple modality biomarker prediction […]

Continue reading...

PPMI 2017 Annual Meeting Summary

May 30, 2017

Nearly 180 PPMI investigators, coordinators, study cores, patient advisory and steering committee members, sponsors, and industry partners from around the world met in New York City May 3-4, 2017 to share PPMI study and scientific updates and to discuss the future of the initiative.  The annual meeting remains a critical component to the study. It […]

Continue reading...

PPMI iPSC Lines — A Valuable Tool for Researchers

Mar 23, 2017

The Parkinson’s Progression Markers Initiative (PPMI) has expanded to include the generation of induced pluripotent stem cell (iPSC) lines from reprogrammed peripheral mononuclear blood cells (PBMCs) collected from PPMI participants. Study leadership hopes to complete 135 blood collections by the end of 2017; to date, over 50 PPMI participants have given blood samples. Cells lines […]

Continue reading...

Live Webinar February 24: 2016 PPMI Data Challenge Winners

Feb 9, 2017

In June of 2016, The Michael J. Fox Foundation challenged data scientists and computational analysts to work with PPMI’s unprecedented collection of open-access clinical, molecular, and imaging data to answer two fundamental questions about Parkinson’s disease: what are the subtypes of the disease, and what baseline factors predict disease progression? In total, forty researchers submitted […]

Continue reading...

The Michael J. Fox Foundation Announces $25,000 PPMI Data Challenge to Advance Parkinson’s Understanding and Study Design

Jun 8, 2016

Today The Michael J. Fox Foundation (MJFF) announced a challenge asking data scientists and computational analysts to work with researchers to answer fundamental questions about Parkinson’s that limit our understanding and slow drug testing. The PPMI Data Challenge offers $25,000 each to two teams that develop models to answer either: • What factors at baseline predict […]

Continue reading...

 

Tags